Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ni Li

Showing results (821-830 of 890) with videos related to

Pageof 89
Sort By:
Plos Medicine|February 22, 2024
Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort studyXuesi Dong, Lingbin Du, Zilin Luo, et al.
Iscience|May 6, 2026
Deformability-augmented mesenchymal stem cells post-enucleation for efficient mRNA intervention of pulmonary fibrosis in rodent modelHao Sun, Xiaojing Qi, Shihan Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2026
Amplification and Overexpression of Cyclin D1 in Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma: A Targeted Next-Generation Sequencing StudyYing-Ren Chen, Po-Min Chiang, Jen Lin, et al.
Nature Communications|May 31, 2022
Imaging the facet surface strain state of supported multi-faceted Pt nanoparticles during reactionMaxime Dupraz, Ni Li, Jérôme Carnis, et al.
Molecular Cell|May 1, 2021
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerabilityQiang Pan, Shanshan Zhong, Hanling Wang, et al.
Journal of the National Cancer Center|July 22, 2024
Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screeningJiang Li, Ping Hu, Jufang Shi, et al.
Cancer Cell|July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling PathwaysHuairui Yuan, Ying Han, Xuege Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2024
Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 DiabetesYuxiao Liu, Weitong Su, Zhengshuai Liu, et al.
Military Medical Research|May 1, 2026
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patientsChen-Ran Wang, Ren-Da Li, Pan Wang, et al.
Nature Cancer|September 6, 2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkersBaijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Pageof 89

Showing results (821-830 of 890) with videos related to

Sort By:
Pageof 89
Plos Medicine|February 22, 2024
Combining fecal immunochemical testing and questionnaire-based risk assessment in selecting participants for colonoscopy screening in the Chinese National Colorectal Cancer Screening Programs: A population-based cohort studyXuesi Dong, Lingbin Du, Zilin Luo, et al.
Iscience|May 6, 2026
Deformability-augmented mesenchymal stem cells post-enucleation for efficient mRNA intervention of pulmonary fibrosis in rodent modelHao Sun, Xiaojing Qi, Shihan Chen, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 16, 2026
Amplification and Overexpression of Cyclin D1 in Epstein-Barr Virus-Positive Inflammatory Follicular Dendritic Cell Sarcoma: A Targeted Next-Generation Sequencing StudyYing-Ren Chen, Po-Min Chiang, Jen Lin, et al.
Nature Communications|May 31, 2022
Imaging the facet surface strain state of supported multi-faceted Pt nanoparticles during reactionMaxime Dupraz, Ni Li, Jérôme Carnis, et al.
Molecular Cell|May 1, 2021
The ZMYND8-regulated mevalonate pathway endows YAP-high intestinal cancer with metabolic vulnerabilityQiang Pan, Shanshan Zhong, Hanling Wang, et al.
Journal of the National Cancer Center|July 22, 2024
Results of the cancer screening feasibility study in China: a multicentered randomized controlled trial of lung and colorectal cancer screeningJiang Li, Ping Hu, Jufang Shi, et al.
Cancer Cell|July 4, 2020
SETD2 Restricts Prostate Cancer Metastasis by Integrating EZH2 and AMPK Signaling PathwaysHuairui Yuan, Ying Han, Xuege Wang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|January 29, 2024
Macrophage CREBZF Orchestrates Inflammatory Response to Potentiate Insulin Resistance and Type 2 DiabetesYuxiao Liu, Weitong Su, Zhengshuai Liu, et al.
Military Medical Research|May 1, 2026
Bridging the lung cancer screening eligibility gap: evaluation of guideline applicability in asymptomatic patientsChen-Ran Wang, Ren-Da Li, Pan Wang, et al.
Nature Cancer|September 6, 2024
Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkersBaijun Dong, Jun-Yu Xu, Yuqi Huang, et al.
Pageof 89